お知らせ • 10h
Anghami Inc. Announces Board and Committee Change
Anghami Inc. announced that In connection with receipt of the Proposal, the Board of Directors of the Company (the "Board") has appointed three new directors: Nathan Scott Fine, Guergui Saykov Stoyanov and Chiara Marcati. The Board has determined that each of the foregoing directors is independent under the listing standards of The Nasdaq Stock Market LLC, has no material relationship with OSN or interest in the Proposal, and is not an employee, affiliate or nominee of OSN. Mr. Fine is an ex-officio (non-voting) Director and Vice Chairman of Rafael Holdings Inc. Previously, Mr. Fine served as Chief Executive Officer of Cyclo Therapeutics, LLC (formerly Cyclo Therapeutics Inc., which since March 2025 has been a wholly-owned subsidiary of Rafael Holdings Inc.). Mr. Fine has been involved in investment banking for over 35 years, working on a multitude of debt and equity financings, mergers and acquisitions, strategic advisory work, and corporate restructurings. Since 2014, he has served on the Board of Kenon Holdings Inc., where he serves as Chair of its Compensation Committee and is a member of its Audit Committee. He previously served as Vice Chairman and Chairman of the Restructuring Committee of Pacific Drilling SA from 2017 to 2018 and as a Director of Central European Distribution Corporation from 1996 until 2014. Mr. Fine attended New Hampshire College. Mr. Stoyanov is the Founder and CEO of StoGeo, a global advisory firm focused on business strategy and next-generation leadership, a position he has held since 2008. Prior to his current role, Mr. Stoyanov served as Partner and Head of Markets at Grant Thornton UAE, and previously held senior positions at EY and PwC in the Middle East, with over 25 years of experience in management consulting, corporate governance, and risk management. Mr. Stoyanov is a Certified Six Sigma Black Belt, Certified Internal Auditor, and Certified Financial Consultant. He holds a Master of Business Administration from London Business School and dual Bachelor of Science degrees in International Business Management and Psychology from the University of Maryland. Ms. Marcati serves as Chief Advisory and Business Officer at AI71, a UAE-headquartered company building agentic, sovereign-grade AI platforms, where she leads strategy, ecosystem partnerships, and public-sector advisory. Previously, she was a Partner at McKinsey & Company, where she led the QuantumBlack AI practice across EMEA and built a 100+ person AI hub delivering applied AI solutions at scale. Ms. Marcati is a frequent speaker on AI governance and transformation, with keynote appearances at global forums including LEAP and the AI Global Summit. She holds degrees in Engineering and Business from the University of Pisa, HEC Paris, and NYU Stern. In response to the Proposal, the Board has formed a special committee (the "Special Committee") composed solely of the three newly appointed independent and disinterested directors, Nathan Scott Fine (Chairman), Guergui Saykov Stoyanov and Chiara Marcati, to review, evaluate and negotiate the Proposal and any potential strategic alternatives, and to determine the course of action that is in the best interests of the Company and its shareholders that are not affiliated with OSN. The Special Committee has been authorized to exercise all lawfully delegable powers of the Board in connection with the Proposal, including the authority to retain independent legal and financial advisors to assist it in its review and deliberations. The Special Committee has full authority to evaluate, negotiate and, if it determines appropriate, to reject the Proposal. The Company will not approve or enter any transaction with OSN without the Special Committee's prior favorable recommendation.